GlaxoSmithKline places its shingles vaccine Shingrix among its top prospects, with peak sales potential of almost $6 billion. Now, Pfizer and BioNTech are joining forces to try to grab a slice of ...
In its first set of financial figures since spinning off its consumer health division, GSK has reported a 19% increase in revenues, driven by burgeoning demand for its shingles vaccine Shingrix ...
KEY POINTS A 77-year-old man presented to the emergency department with a 4-day history of progressive weakness resulting in recurrent sudden falls at home. He also described fever and cough, ...
Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...
StudyFinds on MSN2d
Lake swimming in Iowa led to rare Legionnaires’ disease case that puzzled doctors for daysIn A Nutshell While Legionnaires’ disease typically makes headlines when linked to building water systems, this case shows ...
Bengaluru: India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by ...
GSK's Penmenvy wins FDA approval to protect against five meningococcal serogroups. The CDC panel will vote on usage ...
GSK (GSK) has agreed to sell 500K doses of its avian flu vaccine to Canada to protect the country's at-risk individuals and ...
The Government of Canada has secured an initial supply of 500,000 doses of GSK's bird flu vaccine to protect individuals most ...
The FDA approved GSK’s pentavalent meningococcal vaccine to protect children and young adults aged 10 to 25 years against ...
Following similar deals in countries like the United States and the U.K., Canada is bolstering its stockpile of bird flu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback